The case for randomized trials in cancer treatment: New is not always better

JAMA

Volumn 293, Issue 8, 2005, Pages 1001-1003

  Grann, Alison ^b   Grann, Victor R ^a  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; ECONOMIC ASPECT; EDITORIAL; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RANDOMIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; NEOPLASM; NOTE; RANDOMIZED CONTROLLED TRIAL;

HUMANS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 13944276773     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.8.1001     Document Type: Editorial

References (26)

1. Lafferty WE, Bellas A, Corage Baden A, Tyree PT, Standish U, Patterson R. The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer. 2004;100:1522-1530.
2. Farquhar C, Basser R, Hetrick S, Lethaby A, Marjoribanks J. High-dose chemotherapy and autologous bone marrow or stem cell transplantation vs conventional chemotherapy for women with metastatic breast cancer [update of: Cochrane Database Syst Rev. 2003;(1):CD003142]. Cochrane Database Syst Rev. 2003; (1):CD003142.
3. Farquhar C, Basser R, Hetrick S, Lethaby A, Marjoribanks J. High-dose chemotherapy and autologous bone marrow or stem cell transplantation vs conventional chemotherapy for women with metastatic breast cancer [update of: Cochrane Database Syst Rev. 2003;(1):CD003142]. Cochrane Database Syst Rev. 2003; (1):CD003142.
4. Dignam JJ. The role of cancer cooperative groups within the spectrum of cancer care. Cancer Control. 2004;11:55-63.
5. Kelahan AM, Catalano R, Mariucci D. The history, structure, and achievements of the cancer cooperative groups. Managed Care Cancer. 2001:28-33.
6. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
7. Hyams DM, Mamounas EP, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum. 1997;40:131-139.
8. Wolmark N, Colangelo L, Wieand S. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer. Semin Oncol. 2001;28(suppl 1):9-13.
9. Fisher B, Jeong JH, Dignam J, et al. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. J Natl Cancer Inst Monogr. 2001;30:62-66.
10. Fisher B, Redmond C, Fisher ER. The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology-an overview of findings. Cancer. 1980;46(4suppl):1009-1025.
11. Reaman GH. Pediatric cancer research from past successes through collaboration to future transdisciplinary research. J Pediatr Oncol Nurs. 2004;21:123-127.
12. Fisher RI, Gaynor ER, Dahlberg S, et al. A phase III comparison of CHOP vs m-BACOD vs ProMACE-CytaBOM vs MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study. Ann Oncol. 1994 (suppl 2):91-95.
13. Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003;21:607-614.
14. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90;1371-1388.
15. Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr Opin Urol. 2004;14:143-149.
16. Bruner DW, Movsas B, Konski A, et al. Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual Life Res. 2004;13:1025-1041.
17. ClinicalTrials.gov resources page. Washington, DC: National Institutes of Health. Available at: http://www.clinicaltrials.gov. Accessibility verified January 28, 2005.
18. Soares HP, Kumar A, Daniels S, et al. Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA. 2005;293:970-978.
19. The Alpha-Tocopherol-Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
20. Soares HP, Daniels S, Kumar A, et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ. 2004;328:22-24.
21. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig. 2003;7:2-7.
22. Hellman S, Hellman DS. Of mice but not men: problems of the randomized clinical trial. N Engl J Med. 1991;324:1585-1589.
23. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
24. Kelahan AM. Dissemination of information on legislative mandates and consensus-based programs addressing payment of the costs of routine care in clinical trials through the World Wide Web. Cancer. 2004;100:1238-1245.
25. National Surgical Adjuvant Breast and Bowel Project Web page. Available at: http://www.members.nsabp.pitt.edu/Prevention_News.asp. Accessibility verifed January 31, 2005.
26. Estimated new cancer classes for selected cancer sites by state, US. American Cancer Society Web site. Available at: http://www.cancer.org. Accessibility verifed January 31, 2005.